Leap Therapeutics Earnings miss, Revenue Inline In Q3

  • Investing.com
Leap Therapeutics Earnings miss, Revenue Inline In Q3

Investing.com - Leap Therapeutics reported on Monday third quarter earnings that missed analysts' forecasts and revenue that was inline with expectations.

Leap Therapeutics announced earnings per share of $-0.1300 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.1200 on revenue of $0.00.

Leap Therapeutics shares are down 45% from the beginning of the year and are trading at $0.6949 , down-from-52-week-high.

Leap Therapeutics shares gained 10.99% in intra-day trade the report.

Leap Therapeutics follows other major Healthcare sector earnings this month

Leap Therapeutics's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, compared to forecasts EPS of $2.48 on revenue of $23.36B.

Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, compared to forecast for EPS of $1.91 on revenue of $6.91B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Add Chart to Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100
Please try another search